Radiomics and radiogenomics in head and neck squamous cell carcinoma: Potential contribution to patient management and challenges

Cancer Treat Rev. 2021 Sep:99:102263. doi: 10.1016/j.ctrv.2021.102263. Epub 2021 Jul 26.

Abstract

The application of imaging biomarkers in oncology is still in its infancy, but with the expansion of radiomics and radiogenomics a revolution is expected in this field. This may be of special interest in head and neck cancer, since it can promote precision medicine and personalization of treatment by overcoming several intrinsic obstacles in this pathology. Our goal is to provide the medical oncologist with the basis to approach these disciplines and appreciate their main uses in clinical research and clinical practice in the medium term. Aligned with this objective we analyzed the most relevant studies in the field, also highlighting novel opportunities and current challenges.

Keywords: Head and neck cancer; Imaging biomarkers; Machine learning; Molecular subtypes; Prognostic biomarkers; Radiomics.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor
  • Decision Making
  • Diagnostic Techniques, Radioisotope
  • Head and Neck Neoplasms / diagnostic imaging*
  • Head and Neck Neoplasms / genetics*
  • Head and Neck Neoplasms / therapy
  • Humans
  • Machine Learning
  • Precision Medicine
  • Prognosis
  • Squamous Cell Carcinoma of Head and Neck / diagnostic imaging*
  • Squamous Cell Carcinoma of Head and Neck / genetics*
  • Squamous Cell Carcinoma of Head and Neck / therapy

Substances

  • Biomarkers, Tumor